Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: John Metcalf who wrote (5931)	3/18/2002 1:16:52 AM
From: scaram(o)uche	Respond to of 52153

Yeah, and Kirin has great currency.

To: John Metcalf who wrote (5931)	3/18/2002 2:48:34 AM
From: Crossy	Read Replies (3) \| Respond to of 52153

Mr. Metcalf, Japan Tobacco's pharma interest was sold in 2000 or 2001 to a company called Nichiiko Pharma, 4541.J, very low Price/Sales ratio.. 0.6.. However their webiste is lacking their pipeline schematics.. Was Japan Tobacco's effort substantial from a scientific point of view ?? On ratings of Japanese firms, they are ULTRA CONSERVATIVE, so I wouldn't use that as an indicator for solidity in a field where historically bankruptcies have been nominal (even in Japan). Almost all Pharmas are earning nicely. Even if Sales are down, costs are down even more, so many jap. pharmas brought bottom line indicators like EBTIDA up, not only from a relative point of view but in absolute amounts also.. rgrds CROSSY